Celanese (CE) Cash & Equivalents (2009 - 2026)

Celanese (CE) has 18 years of Cash & Equivalents data on file, last reported at $1.8 billion in Q1 2026.

• Quarterly Cash & Equivalents rose 84.86% year-over-year to $1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 84.86% YoY) and the FY2025 annual result came in at $1.3 billion, up 31.29% from the prior year.
• Cash & Equivalents advanced to $1.8 billion in Q1 2026, from $1.3 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $9.7 billion in Q3 2022 to a low of $605.0 million in Q1 2022.
• A 5-year average of $1.7 billion and a median of $1.3 billion in 2025 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents jumped 621.72% — and 2023, when it tumbled 85.97%.
• Tracing CE's Cash & Equivalents over 5 years: stood at $1.5 billion in 2022, then grew by 19.69% to $1.8 billion in 2023, then sank by 46.7% to $962.0 million in 2024, then soared by 31.29% to $1.3 billion in 2025, then surged by 39.19% to $1.8 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.8 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.